Recent Updates
Recently added Catalysts

Calcium and Vitamin D3

Phase 1

Calcium Deficiency | Small molecule | Endocrine |Takeda Pharmaceutical Company Limited|Last Updated: Oct 18, 2013

Success Probability

Subscribe to view

Market & Valuation

Subscribe to view

Trial Design

UNCONTROLLED
Total Trials1
Total Enrollment55

FDA Designations

No designations recorded

Clinical trial landscape

Calcium and Vitamin D3 · 1 trial · 2 indications

Phase 1 1
NCT01639222Human Pharmacology Trial of Calcium-vitamin D3 Tablet in Healthy ParticipantsCalcium Deficiency
COMPLETED55 Analytics
PHASE1COMPLETED
Human Pharmacology Trial of Calcium-vitamin D3 Tablet in Healthy Participants
Calcium DeficiencyUnlock trial analytics

Study Endpoints

Primary Endpoints

Amount of Calcium Excreted in Urine From 0 Hours up to 6 Hours Post Dose (Ca2+ Ae0-6h)
Day 3 of Period 1 (Reference) and Day 3 in Period 2. Samples were taken 0-6 Hours post dose

Ca2+ Ae0-6h was calculated as the urine volume of the urine collected from 0 to 6 hours multiplied by the calcium concentration measured in urine.

Area Under the Curve From 0 to 6 Hours Post Dose of Parathyroid Hormone (PTH AUC0-6h) in Serum
Day 3 in Period 1 (Reference) and Day 3 in Period 2. Samples were taken at predose, 0.5, 1, 2, 3, 4, and 6 hour post dose.

The area under the curve from 0 to 6 hours post dose of parathyroid hormone (PTH AUC0-6h) in serum, calculated using the linear trapezoidal formula.

Secondary Endpoints

Amount of Calcium Excreted in Urine From 0 to 6 Hours Post Dose Corected for Creatinine (Ae0-6h/Creatinine)
Day 3 of Period 1 (Baseline) and Day 3 in Period 2. Samples will be taken 0-6 Hours postdose
Unlock Study Endpoints

Study Design & Arms

AllocationNA
MaskingNONE
ModelSINGLE_GROUP
PurposeTREATMENT

Treatment Arms

ArmTypeDescription
Calcium 500 mg and Vitamin D3 800 IUEXPERIMENTALPeriod 1: Low calcium meals for up to 3 days. Period 2: Calcium 500 mg and Vitamin D3 800 IU chewable tablets, orally, once daily for up to 3 days with low calcium meals.

Interventions

NameTypeDescription
Calcium 500 mg and Vitamin D3 800 IUDRUGCalcium 500 mg and Vitamin D3 800 IU chewable tablets
Low calcium mealsOTHERA normal Western European diet with reduced calcium content (400 mg per day).
Unlock Study Design Details

Eligibility Criteria

Age Range45 Years to 70 Years
SexALL
Healthy VolunteersYes
Study Sites1

Inclusion Criteria: 1. Is a healthy postmenopausal woman (last menses at least 2 years before signing informed consent and follicle stimulating hormone (FSH) confirming postmenopausal status) or a healthy male aged between 45 to 70 years inclusively 2. Was informed both verbally and in writing abou...

Countries:Germany
Unlock Eligibility Criteria